Efficacy of albendazole ointment on cutaneous larva migrans in 2 young children.

and the other 4 developed morphologic changes while receiving HAART. The average time to morphologic change was 20 months (22 months for those receiving dual nucleoside therapy and 19 months for those receiving HAART). All of the patients in this report received stavudine for an average of 19 months (table 2). As the number of patients receiving antiretroviral therapy increases in the developing world, and patients survive longer with HIV infection, prospective studies investigating metabolic and morphologic changes are needed to better understand regional differences in the risk factors for and presentation of HIV-associated lipodystrophy.